Faculty

Institution

Unit

Venue

Manjunath Nimmakayalu

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Cancer Medicine

Division Of Diagnostic Imaging

School Of Public Health

School of Health Professions

The University of Texas MD Anderson Cancer Center

Manjunath Nimmakayalu is currently serving as a Cancer Medicine Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Manjunath Nimmakayalu

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

genetics molecular biology genomics genome biology molecular diagnostics pathology cancer research tumor biology cancer genomics cancer genetics optical genome mapping omics leukemia nucleic acids variant interpretation genome sequencing dna sequencing long-read sequencing next-generation sequencing myelodysplastic syndromes systems biology epigenetics chromatin cancer immunotherapy immune responses cancer cells clinical laboratory oncogenes brain tumor research cancer discovery biochemical sciences proteome research molecular cell biology biological chemistry cell research cellular biochemistry intellectual disability cytogenetics epigenomics myeloid neoplasia pancreatic cancer cancer immunosurveillance specific resistance biomarker discovery hematological malignancies prognostic biomarkers tumor heterogeneity high throughput sequencing genetic basis medical genetics clinical immunology medical diagnosis biomedical research genome analysis cancer genomes somatic mutation distributions three-dimensional chromatin structure therapeutic significance immunosuppressed tumor microenvironment eight-gene hypoxia signature high-throughput characterization cytogenomic heterogeneity genomic characterization clinical validation infinium cytosnp-850k snp-array gene amplification genetic heterogeneity genomic alterations

Notable Scholarly Works

Notable Federal Grants

Collaborators

O14: Improving Detection of Variant Mecom Rearrangements Through Optical Genome Mapping and Repurposed Targeted Rna-Seq. Genetics in Medicine Open (2026)

molecular diagnosticsgeneticsoptical genome mappingnucleic acidsnext-generation sequencinggenomicsgenome analysisgenome biologymolecular biologygenome editingvariant mecom rearrangements

73. Discovery and Validation of Genomic Alterations by Optical Genome Mapping and Nanopore Long-Read Sequencing. Cancer Genetics (2025)

geneticsgenome sequencingoptical genome mappingnucleic acidsbioinformaticsdna sequencinglong-read sequencinggenomicshigh throughput sequencinggenomic alterationsgenome biologymolecular biologynext-generation sequencing

77. Cytogenomic Characterization of Alk-Negative Alcl Cell Lines DL-40 and Fe-Pd. Cancer Genetics (2025)

biochemical sciencesproteome researchtumor biologymolecular and cellular biologychemical biologycell biologyleukemiamolecular cell biologycell signalingbiological chemistrybiochemistryproteomicscell researchcell and molecular biologymolecular biologymolecular medicinecellular biochemistry

47. Genomic Characterization of the T-All Cell Line Ccrf-Cem Using Optical Genome Mapping and Nanopore Sequencing. Cancer Genetics (2024)

molecular diagnosticsgeneticsmolecular geneticsoptical genome mappingdna sequencinglong-read sequencinggenomic characterizationgenomicsgenome biologymolecular biology

65. Insights Into the Genetic Heterogeneity of Glioblastoma: Gene Amplification in Ecdna and Hsr. Cancer Genetics (2023)

tumor heterogeneitymolecular diagnosticsgeneticscancer genomicsgene amplificationgenetic heterogeneityneuro-oncologyoncogenesbrain tumor researchgliomashuman geneticscancer discoverycancer geneticspathology

Characterization of Mds and Cmml Patients Harboring Trisomy 8 Abnormality: Clinical, Autoimmune, and Mutational Features. Blood (2023)

Hussain AlcassabKoji SasakiDanielle E. HammondAlex BatallerDavid B BeckTapan M. KadiaGuillermo Montalban-BravoKelly S. ChienL. Jeffrey MedeirosHagop KantarjianAwdesh KaliaManjunath NimmakayaluCarlos E. Bueso-RamosGuillermo Garcia-ManeroRashmi Kanagal-Shamanna

hematologymutational featuresgeneticsmedicineautoimmune diseasescmml patientsgenetic basismedical geneticsclinical immunologyimmunologyautoimmunitymedical diagnosis

49. Clinical Validation of Infinium Cytosnp-850K Snp-Array for Routine Copy Number Profiling of Hematological Malignancies. Cancer Genetics (2022)

cancer genomicsmolecular diagnosticsgeneticsclinical validationcancer researchoncologyinfinium cytosnp-850k snp-arraybiomarker discoveryhematological malignanciesbiostatisticsomicspathologyprognostic biomarkershuman geneticscancer geneticsclinical laboratorybiomarkers

High-Resolution Structural Variant Profiling of Myelodysplastic Syndromes by Optical Genome Mapping Uncovers Cryptic Aberrations of Prognostic and Therapeutic Significance. Leukemia (2022)

epigeneticsgeneticsmolecular diagnosticsvariant interpretationchromatintherapeutic significanceleukemiaepigenomicspathologygenome biologymolecular biologymyelodysplastic syndromesomicsmyeloid neoplasia

P767: Clinical Significance of Routine High-Resolution Strucural Variant Profiling in Myelodysplastic Syndromes. HemaSphere (2022)

H. YangG. Garcia-ManeroK. SasakiG. Montalban-BravoZ. TangY. WeiT. KadiaK. ChienD. RushH. NguyenA. KaliaM. NimmakayaluC. Bueso-RamosH. KantarjianL. J. MedeirosR. LuthraR. Kanagal-Shamanna

personalized medicinehematologyvariant interpretationgeneticsmedicineoncologypharmacologyclinical significancemyelodysplastic syndromes

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and is Associated With an Immunosuppressed Tumor Microenvironment. Frontiers in Immunology (2021)

Raefa Abou KhouzamShyama Prasad RaoGoutham Hassan VenkateshNagwa Ahmed ZeinelabdinStephanie BuartMaxime MeylanManjunath NimmakayaluStéphane TerrySalem Chouaib

tumor biologycancer immunotherapyimmune responsescancer researchimmunosuppressed tumor microenvironmentcancer cellspancreatic cancereight-gene hypoxia signaturesystems biologyimmunologycancer immunosurveillancetumor microenvironmentspecific resistance

1
2
10 / page

Manjunath Nimmakayalu

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Cancer Medicine

Division Of Diagnostic Imaging

School Of Public Health

School of Health Professions

The University of Texas MD Anderson Cancer Center

Manjunath Nimmakayalu is currently serving as a Cancer Medicine Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Manjunath Nimmakayalu

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

O14: Improving Detection of Variant Mecom Rearrangements Through Optical Genome Mapping and Repurposed Targeted Rna-Seq. Genetics in Medicine Open (2026)

molecular diagnosticsgeneticsoptical genome mappingnucleic acidsnext-generation sequencinggenomicsgenome analysisgenome biologymolecular biologygenome editingvariant mecom rearrangements

73. Discovery and Validation of Genomic Alterations by Optical Genome Mapping and Nanopore Long-Read Sequencing. Cancer Genetics (2025)

77. Cytogenomic Characterization of Alk-Negative Alcl Cell Lines DL-40 and Fe-Pd. Cancer Genetics (2025)

47. Genomic Characterization of the T-All Cell Line Ccrf-Cem Using Optical Genome Mapping and Nanopore Sequencing. Cancer Genetics (2024)

molecular diagnosticsgeneticsmolecular geneticsoptical genome mappingdna sequencinglong-read sequencinggenomic characterizationgenomicsgenome biologymolecular biology

65. Insights Into the Genetic Heterogeneity of Glioblastoma: Gene Amplification in Ecdna and Hsr. Cancer Genetics (2023)

Characterization of Mds and Cmml Patients Harboring Trisomy 8 Abnormality: Clinical, Autoimmune, and Mutational Features. Blood (2023)

hematologymutational featuresgeneticsmedicineautoimmune diseasescmml patientsgenetic basismedical geneticsclinical immunologyimmunologyautoimmunitymedical diagnosis

49. Clinical Validation of Infinium Cytosnp-850K Snp-Array for Routine Copy Number Profiling of Hematological Malignancies. Cancer Genetics (2022)

High-Resolution Structural Variant Profiling of Myelodysplastic Syndromes by Optical Genome Mapping Uncovers Cryptic Aberrations of Prognostic and Therapeutic Significance. Leukemia (2022)

P767: Clinical Significance of Routine High-Resolution Strucural Variant Profiling in Myelodysplastic Syndromes. HemaSphere (2022)

H. YangG. Garcia-ManeroK. SasakiG. Montalban-BravoZ. TangY. WeiT. KadiaK. ChienD. RushH. NguyenA. KaliaM. NimmakayaluC. Bueso-RamosH. KantarjianL. J. MedeirosR. LuthraR. Kanagal-Shamanna

personalized medicinehematologyvariant interpretationgeneticsmedicineoncologypharmacologyclinical significancemyelodysplastic syndromes

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and is Associated With an Immunosuppressed Tumor Microenvironment. Frontiers in Immunology (2021)

Raefa Abou KhouzamShyama Prasad RaoGoutham Hassan VenkateshNagwa Ahmed ZeinelabdinStephanie BuartMaxime MeylanManjunath NimmakayaluStéphane TerrySalem Chouaib

1
2
10 / page